Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Int Orthop ; 47(11): 2809-2826, 2023 11.
Article in English | MEDLINE | ID: mdl-37612523

ABSTRACT

PURPOSE: The two stage revision procedure is the gold standard surgical technique in chronic shoulder periprosthetic joint infection (PJI). Series of one stage revision have been published with similar outcomes but with preoperative selection of patients. The aim of this work was to report the outcomes (infection eradication, functional, and radiographic) after systematic one stage revision, without preoperative selection of patients, in chronic shoulder PJI. METHODS: This was a retrospective monocentric study including 40 patients (14 women and 26 men) with a diagnosis of periprosthetic joint infection after a shoulder arthroplasty. A one stage shoulder prosthesis revision was performed in all patients, for a PJI evolving for more than three weeks, without preoperative patient selection. The primary endpoint was the absence of signs of persistent infection at a minimum follow-up of two years. Secondary endpoints were clinical and radiological outcomes. RESULTS: At the last follow-up, 36/40 patients had no recurrence of infection after the one stage revision, i.e., 90% of our series. In 45% (18/40) of the cases, the microbial organism was not known at the time of the one stage revision. Cutibacterium acnes was the most frequent pathogen, found in 67.5% (27/40) of the patients. The infection was polymicrobial in 40% (16/40) of the cases. At last follow-up, mean absolute Constant score was 48.4% (16-93) and weighted score was 65.5% (22-100), and satisfaction was evaluated by the patients as excellent or good in 75% (30/40). About 20% (8/40) of the patients had a postoperative complication. CONCLUSION: A one stage revision procedure, combined with appropriate antibiotic therapy, made it possible to eradicate the PJI in 90% of the shoulders in our series with satisfactory functional outcomes.


Subject(s)
Arthritis, Infectious , Arthroplasty, Replacement, Shoulder , Prosthesis-Related Infections , Shoulder Joint , Male , Humans , Female , Arthroplasty, Replacement, Shoulder/adverse effects , Retrospective Studies , Persistent Infection , Prosthesis-Related Infections/epidemiology , Prosthesis-Related Infections/etiology , Prosthesis-Related Infections/surgery , Anti-Bacterial Agents/therapeutic use , Arthritis, Infectious/surgery , Reoperation/adverse effects , Treatment Outcome
2.
J Arthroplasty ; 36(12): 3973-3978, 2021 12.
Article in English | MEDLINE | ID: mdl-34511281

ABSTRACT

BACKGROUND: The use of antibiotic-loaded acrylic cement for treating periprosthetic joint infections remains controversial. We hypothesized that the raw rate of surgical site infection (SSI) is lower after using cement loaded with high-dose gentamicin and clindamycin than after using cement loaded with standard-dose gentamicin for implant fixation during 1-stage hip and knee revision arthroplasty for infection. METHODS: One hundred seventy-one continuous patients operated by 2 experienced surgeons during a 2-year period were included in the study. All patients were followed for 24 months. The primary endpoint was the raw rate of SSI after 2 years of follow-up time. RESULTS: The raw rate of SSI after 2 years of follow-up time was significantly lower in the study group (13%) than in the control group (26%) (P = .03) with an odds ratio of 0.42 (P = .03). These SSIs were new infections rather than a recurrence/persistence of the initial infection. CONCLUSION: The cement used in the study group significantly reduced the risk of SSI relative to the cement used in the control group. Routine use of this high-dose dual antibiotic-loaded cement can be considered during 1-stage knee or hip revision arthroplasty for infection.


Subject(s)
Arthroplasty, Replacement, Hip , Arthroplasty, Replacement, Knee , Prosthesis-Related Infections , Anti-Bacterial Agents/therapeutic use , Arthroplasty, Replacement, Hip/adverse effects , Arthroplasty, Replacement, Knee/adverse effects , Bone Cements , Clindamycin/therapeutic use , Gentamicins , Humans , Prosthesis-Related Infections/drug therapy , Prosthesis-Related Infections/epidemiology , Prosthesis-Related Infections/prevention & control , Reoperation , Retrospective Studies
3.
Open Forum Infect Dis ; 6(7)2019 Jul 01.
Article in English | MEDLINE | ID: mdl-31363768

ABSTRACT

During the 2017-2018 flu epidemic, the point-of-care Alere-i (n = 72) and reverse transcription polymerase chain reaction (n = 106) tests were compared. Patients in the point-of-care group were administered oseltamivir significantly more rapidly (9 hours vs 23 hours), they spent less time in the emergency department, and they had lower rates of antibiotic administration and hospitalization.

4.
J Rheumatol ; 45(3): 425-429, 2018 03.
Article in English | MEDLINE | ID: mdl-29335349

ABSTRACT

OBJECTIVE: To report efficacy and tolerance of interleukin 1 blockade in adult patients with mevalonate kinase deficiency (MKD). METHODS: We retrospectively collected data on 13 patients with MKD who had received anakinra (n = 10) and canakinumab (n = 7). RESULTS: Anakinra resulted in complete or partial remission in 3/10 and 5/10 patients, respectively, and no efficacy in 2/10, but a switch to canakinumab led to partial remission. Canakinumab resulted in complete or partial remission in 3/7 and 4/7 patients, respectively. CONCLUSION: These data support frequent partial responses, showing a better response with canakinumab. The genotype and therapeutic outcomes correlation should help in the personalization of treatment.


Subject(s)
Antibodies, Monoclonal/therapeutic use , Antirheumatic Agents/therapeutic use , Interleukin 1 Receptor Antagonist Protein/therapeutic use , Mevalonate Kinase Deficiency/drug therapy , Adolescent , Adult , Antibodies, Monoclonal/pharmacology , Antibodies, Monoclonal, Humanized , Antirheumatic Agents/pharmacology , Chemical and Drug Induced Liver Injury , Child , Child, Preschool , Drug Tolerance , Female , France , Humans , Infections/chemically induced , Injection Site Reaction/etiology , Interleukin 1 Receptor Antagonist Protein/adverse effects , Interleukin 1 Receptor Antagonist Protein/pharmacology , Interleukin-1beta/antagonists & inhibitors , Male , Precision Medicine , Remission Induction , Retrospective Studies , Treatment Outcome , Weight Gain/drug effects
5.
Opt Express ; 13(14): 5387-92, 2005 Jul 11.
Article in English | MEDLINE | ID: mdl-19498533

ABSTRACT

We report on transient laser action during the photopolymerization process in organic thin films of acrylate monomers doped with a laser dye. The emission spectrum was monitored over a period of time in the direction orthogonal to the incident laser beam which is kept at a constant intensity during the experiments. The emission spectra display the signature of laser action after a certain amount of polymerization. We have also recorded the intensity of fluorescence as well as of the amplified stimulated emission (ASE) using a photodiode. Our results confirmed that all the emission is guided by an increase of the refractive index resulting from the photopolymerization process. The spatial fluctuations in the density of the material are thought to act as micro-cavities leading to a random laser effect.

SELECTION OF CITATIONS
SEARCH DETAIL
...